Search for: "Pfizer Pharmaceutic, Inc." Results 441 - 460 of 667
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2008, 11:14 am
For information about the settlement with First Databank and also with Medispan, Inc., go here. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs)   Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
5 Oct 2016, 11:44 am by John Suthers
  In another similar case involving a drug manufacturer, a former sales representative of Pfizer, Inc., brought a qui tam lawsuit, alleging the manufacturer engaged in off-label marketing of its painkiller, Bextra. [read post]
5 Oct 2016, 11:44 am by John Suthers
  In another similar case involving a drug manufacturer, a former sales representative of Pfizer, Inc., brought a qui tam lawsuit, alleging the manufacturer engaged in off-label marketing of its painkiller, Bextra. [read post]
17 May 2011, 10:37 pm
Endo Pharmaceuticals appealed three applications related to time-released opioids. [read post]
27 May 2009, 4:09 am
Pfizer Inc. more than doubled its spending on lobbying in the period to $6.1 million.Earlier this month, drug makers joined doctors, insurers and hospitals in a pledge to rein in health-care cost increases by $2 trillion over the next decade. [read post]
18 Jan 2013, 2:06 pm by Bexis
  The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
2 Jun 2011, 12:46 pm by Bexis
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]
3 Mar 2016, 5:19 am
Pfizer, Inc., 153 S.W.3d 758, 766 (Ky. 2004) (DTC exception “recognized only by New Jersey”); Mendez Montes De Oca v. [read post]
3 Nov 2010, 1:21 am by Kelly
General Bell tolls for biodiversity benefit-sharing treaty (IP Watch) Ministers arrive to help reach outcome at UN convention on biodiversity (IP Watch) Delegates see UN protocol against biopiracy within reach (IP Watch) Pfizer and Biocon sign global commercialisation agreement on biosimilars (Patent Docs) Brazil: Paragraph 6 system: Brazilian intervention at the WTO TRIPS Council (KEI) Canada’s intervention to TRIPS Council: Experience using the System (Apotex-Rwanda Case) (KEI)… [read post]
27 May 2010, 3:40 pm by Bexis
Merrell Dow Pharmaceuticals, Inc., 791 F. [read post]
10 Aug 2011, 4:30 am by Marie Louise
(Patent Docs) Relpax (Eletripian hydrobromide) – Pfizer settles Relpax infringement suit with Apotex (Patent Docs) Solodyn (Minocycline) – US: Medicis and Lupin settle Solodyn infringement dispute; Agree to drug development collaboration (Patent Docs) Viagra (Sildenafil citrate) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
10 Jun 2015, 6:00 am by JB
The NLDC wanted to redevelop an economically troubled neighborhood in conjunction with Pfizer, Inc., a major pharmaceutical firm that had set up a headquarters nearby and expected to benefit from the takings.The sad history of the project does indeed highlight some of the weaknesses of the Kelo decision. [read post]
22 Feb 2008, 1:30 pm
In a crushing blow to consumers, on Thursday, February 21st, the United States Supreme Court again sided with big pharmaceutical medical device makers. [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid: (IPLaw360), … [read post]